Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
General Rheumatology
•
Contraception
•
Transgender Care
How do you approach contraception counseling with transgender patients taking gender affirming hormone therapy prior to starting teratogenic medications?
Related Questions
Have you utilized combination biologic therapy for the treatment of rheumatic diseases?
How would you approach treatment of active inflammatory arthritis in a patient with MCTD (+RNP/+Chromatin) and stable ILD who has failed MMF, azathioprine and methotrexate?
Would you feel comfortable adding benlysta to patient already taking both mycophenolate and tacrolimus (and hydroxychloroquine) who still has some evidence of active lupus nephritis?
What characteristics make a PMR patient a good candidate for sarilumab?
How do you approach initiation/continuation of biologics if there is a suspicious pulmonary nodule that requires close interval imaging (i.e every 3 or 6 months)?
Do you typically adjust or hold immunosuppression in a well-controlled RA patient who is being treated for Mycobacterium avium-intracellulare (MAI)?
Have you seen drug induced SCLE from IL-17 inhibitors?
How do you approach the work up of pulmonary artery aneurysm in the absence of other clinical features of Behcet’s?
How do you approach pre-conception counseling in males who are on medications for which there is limited or no data such as Jak inhibitors, apremilast, or belimumab?
How do you counsel patients regarding alcohol intake when prescribing DMARDs other than methotrexate?
